Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs). Its protected amine group allows for selective reactions in multi-step organic syntheses, making it valuable in constructing complex drug molecules. Commonly employed in the preparation of kinase inhibitors and other bioactive compounds where the fluorine atom enhances metabolic stability and binding affinity. Also utilized in research settings for the design of novel therapeutic agents in medicinal chemistry.